Delivery Order SPE2DB20D6035-SPE2DB25FLXNR

Award Date 1/22/25
Potential Completion Date 1/23/25
Potential Value $5.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D3101|SPE2DB25FQYH6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Freestyle Libre 3 Sensors, a medical device used for diabetes management. The award has a ceiling value of $2,288.85 and an ultimate completion date of January 7, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and...
This federal contract award, with ID SPE2DB20D3303|SPE2DB25FY6S1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Freestyle Libre 3 Sensors, a medical device used for diabetes management. The contract has a ceiling value of $12,501.62 and an ultimate completion date of December 23, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing mechanism. This award is not designated with any...
This federal contract award, with ID SPE2DB20D3303|SPE2DB24FZ8B0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Freestyle Libre 3 Sensors, a medical device used for diabetes management, with a ceiling value of $9,069.10. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This federal contract award, valued at $1,963.86, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Freestyle Libre 3 Sensors, a medical device used for diabetes management. The contract has an ultimate completion date of January 27, 2025 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider, and this award is part of a...
This federal contract award, with an ID of SPE2DB22D3301|SPE2DB25FX5ZF, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Freestyle Libre 3 Sensors, a medical device used for diabetes management. The award has a ceiling value of $58,438.56 and is structured as a Firm Fixed Price Delivery Order, with a period of performance running through November 25, 2024....
This federal contract award, with the ID SPE2DB20D1110|SPE2DB25FJ76Q, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,945.09, is for the delivery of Freestyle Libre 3 Sensors, a medical device used for diabetes management. The contract has an ultimate completion date of November 18, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is the...
This federal contract award, with the identifier SPE2DB22D3011|SPE2DB25FP7XX, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Freestyle Libre 3 Sensors, a medical device for diabetes management. The contract has a total ceiling value of $18,753.29 and is a firm fixed-price delivery order with a completion date of December 6, 2024. The contract was awarded on December 5, 2022 and is not designated as a...
This federal contract award, valued at $1,209.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Freestyle Libre 3 Sensors, a medical device used in the management of diabetes. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the provision of Freestyle Libre 3 Sensors, a medical device used for diabetes management, with a ceiling value of $17,304.20. The contract is a firm fixed price delivery order with a completion date of November 8, 2024. This award is part of a larger $999,999,999 Indefinite Delivery...
This federal contract award, valued at $1,042.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Freestyle Libre 3 Sensors, a medical device used for diabetes management. The contract has an ultimate completion date of January 3, 2025 and is structured as a firm fixed-price delivery order. This award is not associated with a set-aside designation, indicating...
  • SPE2DB20D6035
    Indefinite Delivery Contract
  • SPE2DB20D6035-SPE2DB25FLXNR
    Delivery Order

This federal contract award, with the ID SPE2DB20D6035|SPE2DB25FLXNR, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Freestyle Libre 3 sensors, a medical device used for diabetes management. The contract has a ceiling value of $5,093.18 and is a Delivery Order with a Firm Fixed Price pricing type. The contract has an ultimate completion date of January 23, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the prime contractor, and there is no information provided about any subcontractors. The DLA, which is a defense agency, is the funding agency for this contract.

Generated 4/23/25, 9:57 AM